Autoantibodies in the nervous system: pathophysiology and new therapeutic strategies

Keyphrases

• Pathophysiology 100%
• Autoantibodies 100%
• Myasthenia Gravis 100%
• New Therapeutic Strategies 100%
• Nervous System 100%
• Autoimmune Disease 50%
• Disease Mechanisms 50%
• Tolerability 50%
• Treatment Efficacy 50%
• Systemic Immune Response 50%
• Neurological Disorders 50%
• Psychotic Disorders 50%
• Virus 50%
• Protease Inhibitors 50%
• Muscle Weakness 50%
• Neural Autoantibodies 50%
• Psychotic Symptoms 50%
• Plasma Cells 50%
• Disease Phenotype 50%
• Acetylcholine Receptor (AChR) 50%
• Antibody-mediated 50%
• Cell Surface Receptor 50%
• Accurate Diagnosis 50%
• Own Body 50%
• Immune Suppression 50%
• Patient-specific Therapy 50%
• DOK7 50%
• Susceptibility Factors 50%
• Muscle Fatigue 50%
• Autoimmune Encephalitis 50%
• Ixazomib 50%
• Novel Treatments 50%
• Accurate Treatment 50%

INIS

• antibodies 100%
• nervous system 100%
• diseases 40%
• receptors 40%
• patients 20%
• therapy 20%
• increasing 20%
• tissues 20%
• damage 20%
• symptoms 20%
• suppression 20%
• design 20%
• phenotype 20%
• muscles 20%
• organs 20%
• fatigue 20%
• viruses 20%
• tolerance 20%
• surfaces 20%
• bacteria 20%
• acetylcholine 20%
• pathogens 20%
• plasma cells 20%
• encephalitis 20%

Immunology and Microbiology

• Monospecific Antibody 100%
• Nervous System 100%
• Autoantibodies 100%
• Myasthenia gravis 50%
• Infectious Agent 25%
• Surface Property 25%
• Autoimmune Disease 25%
• Proteasome 25%
• Plasma Cell 25%
• Autoimmune Encephalitis 25%